 | • レポートコード：GIR-22F19636 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Solifenacin Succinate Drug Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のソリフェナシンコハク酸塩製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ソリフェナシンコハク酸塩製剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・5mg錠、10mg錠 アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア 世界のソリフェナシンコハク酸塩製剤市場の主要な市場プレーヤーは以下のとおりです。 ・Astellas Pharma、Teva、Ajanta Pharma、Aurobindo Pharma、Glenmark Pharmaceuticals、Qilu Pharmaceutical、Cipla、Jiangxi Boya Seehot Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ソリフェナシンコハク酸塩製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なソリフェナシンコハク酸塩製剤メーカーの企業概要、2019年～2022年までのソリフェナシンコハク酸塩製剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なソリフェナシンコハク酸塩製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ソリフェナシンコハク酸塩製剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのソリフェナシンコハク酸塩製剤のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのソリフェナシンコハク酸塩製剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびソリフェナシンコハク酸塩製剤の産業チェーンを掲載しています。 ・第13、14、15章では、ソリフェナシンコハク酸塩製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - ソリフェナシンコハク酸塩製剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：5mg錠、10mg錠 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア - 世界のソリフェナシンコハク酸塩製剤市場規模・予測 - 世界のソリフェナシンコハク酸塩製剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Astellas Pharma、Teva、Ajanta Pharma、Aurobindo Pharma、Glenmark Pharmaceuticals、Qilu Pharmaceutical、Cipla、Jiangxi Boya Seehot Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：5mg錠、10mg錠 ・アプリケーション別分析2017年-2028年：病院、ドラッグストア ・ソリフェナシンコハク酸塩製剤の北米市場分析 - ソリフェナシンコハク酸塩製剤の北米市場：タイプ別市場規模2017年-2028年 - ソリフェナシンコハク酸塩製剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ソリフェナシンコハク酸塩製剤のヨーロッパ市場分析 - ：ソリフェナシンコハク酸塩製剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ソリフェナシンコハク酸塩製剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ソリフェナシンコハク酸塩製剤のアジア太平洋市場分析 - ソリフェナシンコハク酸塩製剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ソリフェナシンコハク酸塩製剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ソリフェナシンコハク酸塩製剤の南米市場分析 - ソリフェナシンコハク酸塩製剤の南米市場：タイプ別市場規模2017年-2028年 - ソリフェナシンコハク酸塩製剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ソリフェナシンコハク酸塩製剤の中東・アフリカ市場分析 - ソリフェナシンコハク酸塩製剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ソリフェナシンコハク酸塩製剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Solifenacin Succinate Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Solifenacin Succinate Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Solifenacin Succinate Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5 mg Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Solifenacin Succinate Drug include Astellas Pharma, Teva, Ajanta Pharma, Aurobindo Pharma, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Solifenacin Succinate Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg Tablet
10 mg Tablet
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Solifenacin Succinate Drug market are listed below:
Astellas Pharma
Teva
Ajanta Pharma
Aurobindo Pharma
Glenmark Pharmaceuticals
Qilu Pharmaceutical
Cipla
Jiangxi Boya Seehot Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Solifenacin Succinate Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Solifenacin Succinate Drug, with price, sales, revenue and global market share of Solifenacin Succinate Drug from 2019 to 2022.
Chapter 3, the Solifenacin Succinate Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Solifenacin Succinate Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Solifenacin Succinate Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Solifenacin Succinate Drug.
Chapter 13, 14, and 15, to describe Solifenacin Succinate Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Solifenacin Succinate Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Solifenacin Succinate Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Solifenacin Succinate Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Solifenacin Succinate Drug Market Size & Forecast
1.4.1 Global Solifenacin Succinate Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Solifenacin Succinate Drug Sales in Volume (2017-2028)
1.4.3 Global Solifenacin Succinate Drug Price (2017-2028)
1.5 Global Solifenacin Succinate Drug Production Capacity Analysis
1.5.1 Global Solifenacin Succinate Drug Total Production Capacity (2017-2028)
1.5.2 Global Solifenacin Succinate Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Solifenacin Succinate Drug Market Drivers
1.6.2 Solifenacin Succinate Drug Market Restraints
1.6.3 Solifenacin Succinate Drug Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Solifenacin Succinate Drug Product and Services
2.1.4 Astellas Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Solifenacin Succinate Drug Product and Services
2.2.4 Teva Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ajanta Pharma
2.3.1 Ajanta Pharma Details
2.3.2 Ajanta Pharma Major Business
2.3.3 Ajanta Pharma Solifenacin Succinate Drug Product and Services
2.3.4 Ajanta Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Solifenacin Succinate Drug Product and Services
2.4.4 Aurobindo Pharma Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Solifenacin Succinate Drug Product and Services
2.5.4 Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Solifenacin Succinate Drug Product and Services
2.6.4 Qilu Pharmaceutical Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Solifenacin Succinate Drug Product and Services
2.7.4 Cipla Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Jiangxi Boya Seehot Pharmaceutical
2.8.1 Jiangxi Boya Seehot Pharmaceutical Details
2.8.2 Jiangxi Boya Seehot Pharmaceutical Major Business
2.8.3 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product and Services
2.8.4 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Solifenacin Succinate Drug Breakdown Data by Manufacturer
3.1 Global Solifenacin Succinate Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Solifenacin Succinate Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Solifenacin Succinate Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Solifenacin Succinate Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Solifenacin Succinate Drug Manufacturer Market Share in 2021
3.5 Global Solifenacin Succinate Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Solifenacin Succinate Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Solifenacin Succinate Drug Market Size by Region
4.1.1 Global Solifenacin Succinate Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Solifenacin Succinate Drug Revenue by Region (2017-2028)
4.2 North America Solifenacin Succinate Drug Revenue (2017-2028)
4.3 Europe Solifenacin Succinate Drug Revenue (2017-2028)
4.4 Asia-Pacific Solifenacin Succinate Drug Revenue (2017-2028)
4.5 South America Solifenacin Succinate Drug Revenue (2017-2028)
4.6 Middle East and Africa Solifenacin Succinate Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Solifenacin Succinate Drug Sales in Volume by Type (2017-2028)
5.2 Global Solifenacin Succinate Drug Revenue by Type (2017-2028)
5.3 Global Solifenacin Succinate Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Solifenacin Succinate Drug Sales in Volume by Application (2017-2028)
6.2 Global Solifenacin Succinate Drug Revenue by Application (2017-2028)
6.3 Global Solifenacin Succinate Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Solifenacin Succinate Drug Sales by Type (2017-2028)
7.2 North America Solifenacin Succinate Drug Sales by Application (2017-2028)
7.3 North America Solifenacin Succinate Drug Market Size by Country
7.3.1 North America Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Solifenacin Succinate Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Solifenacin Succinate Drug Sales by Type (2017-2028)
8.2 Europe Solifenacin Succinate Drug Sales by Application (2017-2028)
8.3 Europe Solifenacin Succinate Drug Market Size by Country
8.3.1 Europe Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Solifenacin Succinate Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Solifenacin Succinate Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Solifenacin Succinate Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Solifenacin Succinate Drug Market Size by Region
9.3.1 Asia-Pacific Solifenacin Succinate Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Solifenacin Succinate Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Solifenacin Succinate Drug Sales by Type (2017-2028)
10.2 South America Solifenacin Succinate Drug Sales by Application (2017-2028)
10.3 South America Solifenacin Succinate Drug Market Size by Country
10.3.1 South America Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Solifenacin Succinate Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Solifenacin Succinate Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Solifenacin Succinate Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Solifenacin Succinate Drug Market Size by Country
11.3.1 Middle East & Africa Solifenacin Succinate Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Solifenacin Succinate Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Solifenacin Succinate Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Solifenacin Succinate Drug
12.3 Solifenacin Succinate Drug Production Process
12.4 Solifenacin Succinate Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Solifenacin Succinate Drug Typical Distributors
13.3 Solifenacin Succinate Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer